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BACKGROUND: Many kinds of solid tumour have heterogeneously a hypoxic environment. Tumour hypoxia reported to be associated
with more aggressive tumour phenotypes such as high metastatic ability and resistance to various anti-cancer therapies which may
lead to a poorer prognosis. However, the mechanisms by which hypoxia affects the aggressive phenotypes remain unclear.
METHODS: We established a scirrhous gastric carcinoma cell line (OCUM-12) from ascites associated with scirrhous gastric carcinoma,
and a hypoxia-resistant cancer cell line (OCUM-12/Hypo) was cloned from OCUM-12 cells by continuous exposure to 1% oxygen.
RESULTS: Histologic findings from orthotopic tumours derived from parent OCUM-12 cells and daughter OCUM-12/Hypo cells
revealed poorly differentiated adenocarcinoma with extensive fibrosis that resembled human scirrhous gastric cancer. Necrotic
lesions were frequently detected in the OCUM-12 tumours but were rarely found in the OCUM-12/Hypo tumours, although both
types had multiple hypoxic loci. Apoptosis rate of OCUM-12 cells was increased to 24.7% at 1% O2, whereas that of OCUM-12/
Hypo was 5.6%. The OCUM-12/Hypo orthotopic models developed multiple metastases to the peritoneum and lymph nodes, but
the OCUM-12 models did not. OCUM-12/Hypo cells showed epithelial-to-mesenchymal transition and high migratory and invasive
activities in comparison with OCUM-12 cells. The mRNA expression levels of both E-cadherin and zonula occludens ZO-1 and
ZO-2 decreased in OCUM-12/Hypo cells, and that of vimentin, Snail-1, Slug/Snail-2, Twist, ZEB-1, ZEB-2, matrix metalloproteinase-1
(MMP-1), and MMP-2 were increased in OCUM-12/Hypo cells.
CONCLUSION: OCUM-12 and OCUM-12/Hypo may be useful for the elucidation of disease progression associated with scirrhous
gastric cancer in the setting of chronic hypoxia.
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Most solid tumours are hypovascular and possess microscopically
heterogeneous hypoxic regions (Vaupel et al, 1987, 2003; Hockel
et al, 1996; Driessen et al, 2006; Mayer et al, 2008). Cancer cells
under hypoxic conditions are reported to show malignant features,
such as high metastatic ability and resistance to various anti-cancer
therapies (Harris and Shrieve, 1979; Ludwig, 1984; Driessen et al,
2006); however, the mechanisms by which hypoxia affects cancer
progression remain unclear. Hypoxia alters important intracellular
pathways, and it is recognized as a stimulus for the malignant
potential (Semenza, 2002; Subarsky and Hill, 2003; Vaupel, 2004).
The hypoxic condition is heterogeneous not only regarding location,
but also regarding duration (such as acute or chronic hypoxia)
(Hockel and Vaupel, 2001). Although the effect of acute hypoxia on
the phenotype of cancer cells has been often studied (Brown, 1979),
few reports of chronic hypoxia have been published (Song et al,
2001; Kim et al, 2009a). Cancer cells may frequently be exposed
to continuous hypoxia because of their hypovascular nature.
A hypoxia-resistant cell line might be useful for the study of cancer
phenotypes under conditions of chronic hypoxia, however, to the
best of our knowledge, so far there has been no report of the
establishment of a hypoxia-resistant cell line. We established a new
hypoxia-resistant cancer cell line derived from scirrhous gastric
carcinoma, designated as OUCM-12/Hypo, that continued to grow
in 1% oxygen. Human scirrhous gastric carcinoma (also known as
linitis plastica carcinoma) is a diffuse-type gastric cancer characterized
by cancer cell infiltration and proliferation and accompanied by
extensive stromal fibrosis (Tahara, 1990). It may grow in hypoxic
conditions due to a lesser degree of angiogenesis in comparison to
intestinal-type carcinoma (Takahashi et al, 1996). Characterization
of hypoxia-resistant cancer cells might elucidate the behaviour of
scirrhous gastric carcinoma in hypoxic conditions.
MATERIALS AND METHODS
Patients
OCUM-12 was derived from ascites of a 58-year-old man with
peritoneal dissemination of gastric carcinoma in 2004. Upper
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sgastrointestinal series (Figure 1A) and gastroendoscopic examina-
tion (Figure 1B) found diffusely infiltrating gastric carcinomas
in which ulceration is usually not a marked feature (Japanese
Gastric Cancer Association, 1998). Examination of the biopsy
specimen from primary gastric tumour revealed that it has the
characteristic morphology of poorly differentiated adenocarcinoma
accompanied by stromal cells (Figure 1C). Therefore, the
primary tumour was diagnosed as scirrhous types of gastric
carcinoma (Japanese Gastric Cancer Association, 1998). The tissue
sections were subjected to immunohistochemical staining using
antibodies against carbonic anhydrase 9 (CA9; 1:1000; Novus
Biologicals, Littleton, CO, USA), and hypoxia-inducible factor-1a
(HIF-1a; 1:25; Novus Biologicals). The staining of hypoxia-
associated endogenous proteins, HIF-1a and CA9, was hetero-
geneously positive in cancer cells of both biopsy specimen and
peritoneal metastasis (Figure 1C). Informed consent was obtained
from the patients from whom the tumour specimens were
obtained.
Establishment of cell lines and cell culture
Abdominal effusion from a patient was collected aseptically into a
bottle with heparin then centrifuged at 1000r.p.m. for 5min. The
pellet was suspended in 10ml culture medium (see below) and
seeded into 100mm culture dishes (Falcon, Lincoln Park, NJ,
USA). Initial culture was performed in a humidified incubator at
371C in an atmosphere of 5% carbon dioxide and 95% air. The
culture medium was Dulbecco’s modified Eagle’s medium (DMEM;
Wako, Osaka, Japan) with 10% heat-inactivated fetal bovine serum
(FBS; Nichirei Biosciences, Tokyo, Japan), 100IUml
 1 penicillin
(Sigma, Steinheim, Germany), 100mgml
 1 streptomycin (Sigma),
and 0.5mM sodium pyruvate (Sigma). Floating cells and adherent
mesothelial cells were found in a dish. Floating cells were collected
and re-suspended in medium. Serial passages were carried out
every 4–7 days. The cells were passaged routinely at a ratio of
1:5 or 1:10. The floating cell lines were designated OCUM-12.
OCUM-12 cell was carried for more than 48 months and passaged
for more than 200 generations. A new hypoxia-resistant cell line
was established from OCUM-12, as follows: OCUM-12 cells at
180th passage generations were cultured in a humidified incubator
at 371C in an atmosphere of 5% carbon dioxide and 5% oxygen for
4 weeks. Although most of OCUM-12 cells were dead under
hypoxic condition, some cancer cells were alive and grew gradually
under 5% oxygen. Then, surviving cells were cultured for 6 weeks
in 1% oxygen. Most cells were dead at initial culture, some cancer
cells began to grow under 1% oxygen conditions. Proliferative
cancer cells under 1% oxygen were designated OCUM-12/Hypo as
a new hypoxia-resistant cell line. OCUM-12/Hypo cell was cultured
for more than 5 months and passaged for more than 20
generations. Both cell lines were tested for Mycoplasma contami-
nation with a Hoechst staining kit (Flow, Tokyo, Japan).
Morphologic findings were investigated with a phase-contrast
microscope. Cells were stained with hematoxylin and eosin (H&E).
All experimental studies using OCUM-12 cells were carried out
at 20% O2, and those using OCUM-12/Hypo cells were carried
out at 1% O2.
Growth kinetics
The doubling time of OCUM-12 and OCUM-12/Hypo cells was
determined at the 190th and 10th passages, respectively. Briefly,
suspensions of 1.0 10
4 cells were incubated in 24-well dishes with
1ml DMEM containing 10% FCS. Number of cancer cells was
counted every 24h by counting chamber. The doubling times
were determined from the growth curve. Production of tumour-
associated antigen was examined as follows: a suspension
of 1.0 10
6 cells in 100mm plastic culture dishes was incubated
for 3 days in culture medium. Then, production levels of tumour-
associated antigens, carcinoembryonic antigen (CEA), carbo-
hydrate 19-9 (CA19-9), SPan-1, and a-fetoprotein (AFP), in the
spent medium were measured by radioimmunoassay as previously
reported (Yashiro et al, 1995).
Chromosome analysis
Cells were karyotyped using a standard air-dried method (Seabright,
1971) after treatment with a final concentration of 0.05mgml
 1
colcemid for 2h when the cells were in an exponential growth
phase. They were analysed using trypsin G banding. A total of 50
metaphase spreads were counted to determine the modal number.
Karyotyping was performed according to the International System
for Human Cytogenetic Nomenclature (Seabright, 1971). Chromo-
some analysis was carried out on the two cell lines at the 40th
passage.
DNA extraction
Genomic DNA of primary gastric tumour was extracted from the
biopsy specimens after it had been fixed in 10% buffered formalin
and embedded in paraffin. One section was stained with H&E and
used as a reference for selecting areas for microdissection from
adjacent sections, using a sterile scalpel blade under a dissecting
microscope. Genomic DNA of OCUM-12 and OCUM-12/Hypo cells
was extracted with phenol–chloroform. The genomic DNA was
isolated from the paraffin-embedded microdomains removed
from the sections using Proteinase K (Gibco Life Technologies,
Gaithersburg, MD, USA) at a final concentration of 100mgml
 1
and was incubated for 5h at 551C.
HIF-1α
CA9
H&E
Primary gastric tumour Peritoneal metastatic tumour
Figure 1 Upper gastrointestinal series (A) and gastro-fibrscopy (B)
showed diffusely infiltrating carcinomas in which ulceration is usually not a
marked feature (arrows). Histology of the primary tumour and the
peritoneal metastatic tumour showed poorly differentiated adenocarcino-
ma (C). Primary gastric tumour accompanied by fibrosis. Immunostaining of
hypoxia-inducible factor-1a (HIF-1a) and carbonic anhydrase 9 (CA9)
showed that hypoxic lesions were present in both the primary tumour and
the peritoneal metastatic tumour (C).
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sPCR-LOH/MSI assay
Microsatellite instability (MSI) and loss of heterozygosity (LOH)
were analysed by PCR-LOH/MSI assay, as previously reported
(Fujiwara et al, 2008). A 6ml aliquot of reaction mixture was
formulated using 0.4ml of DNA extracted from normal epithelium,
primary tumour, OCUM-12, and OCUM-12/Hypo cells. 4.5ml
of each primer marker set, 0.06ml AmpliTaq Gold (Applied
Biosystems, Foster City, CA, USA), and 1.04ml distilled water.
Four primer marker sets – TP53Penta, D18S35, D3S1611, and
D5S346 – were linked to the p53 loci on 17p13, the DCC/DPC4
locus on 18q21, the hMLH1 locus on 3p23-21.3, and the APC locus
on 5q21. The polymerase chain reaction (PCR) conditions were as
follows: 951C for 10min followed by 45 cycles (961C for 10s, 551C
for 30s, 701C for 3min), with a final elongation at 701C for 30min.
Each sample was analysed by the ABI PRISM 310 Genetic Analyzer
(Applied Biosystems). A tumour was determined as exhibiting
LOH if there was absence or more than a 50% reduction in the
peak height of one allele of the tumour sample compared to the
normal epithelium allele.
Orthotopic tumour models
Orthotopic implantation was performed as previously reported
(Yashiro et al, 1996; Takemura et al, 2004). Four-week-old BALB/c
nude mice (Oriental Kobo, Osaka, Japan) was used as xenograft
recipient for human tumour fragments. OCUM-12 cells (1.0 10
7)
and OCUM-12/Hypo cells (1.0 10
7) suspended in a volume of
100ml DMEM were inoculated orthotopically into five mice at each
experiment. Under ether anaesthesia, a median abdominal incision
was made in nude mice. The stomach was exposed carefully, and
1.0 10
7 cells were inoculated at the gastric antrum using 30-gauge
needles (Handaya, Saitama, Japan). Seven weeks after inoculation,
the hypoxic cell marker pimonidazole hydrochloride (Hypoxy-
prove-1 kit; Chemicon, Temecula, CA, USA) was used to delineate
the hypoxic site of the tumours due to its specific binding to cells
in a partial oxygen tension o10mmHg, as previously reported
(Furuta et al, 2008). Pimonidazole (60mgkg
 1) was injected to
the mouse through tail vein injection 90min before the animals
were killed. Upon killing the animal, the subcutaneous tumours,
the gastric tumour, and metastatic tumours were removed and
fixed in 10% formalin for paraffin sections and stained with H&E
and Masson’s trichrome. The selected tissue sections were subjected
to immunohistochemical staining using antibodies against pimoni-
dazole (1:50, hypoxyprobe-1; Chemicon), CA9, and HIF-1a.A n i m a l
experiments were performed in compliance with the guidelines of the
Osaka City University Ethical Committee.
Wound-healing assays
The in vitro wound-healing ability was measured using the method
of Borensztajn et al (2008) with some modifications. Gastric cancer
cells were cultured in six-well plates. After the cells reached semi-
confluence, a wound was created in the cell monolayer by a pipette
tip. Cancer cells were cultured for additional 48h at 371C. Four
scratched fields were randomly chosen and the number of migration
cells was counted. The culture was performed in duplicate.
Invasion assay
The in vitro invasiveness was measured using the method of Albini
et al (1987) with some modifications. We used the chemotaxicell
chambers with a 12mm pore membrane filter (Kubota, Osaka,
Japan) coated with 50mg of Matrigel in a 24-well culture plate.
OCUM-12 and OCUM-12/Hypo cells were re-suspended to a final
concentration of 1.0 10
4 cells per ml in DMEM with 10% FBS.
After incubation for 72h in an atmosphere of 1 and 20% oxygen,
cancer cells on the upper surface of the membrane were removed
by wiping. The membrane was stained with hematoxylin. Cancer
cells that invaded through a filter coated with Matrigel to the lower
membrane were manually counted under a microscope at  200
magnification. Four randomly chosen fields were counted for each
assay. The mean of six fields was calculated as the sample value.
For each group, the culture was performed in triplicate.
Reverse transcription–PCR (RT–PCR)
Total cellular RNA was extracted from OCUM-12 and OCUM-12/
Hypo gastric cancer cell lines (each cell lines incubate 20 and 1%
oxygen for 24h) with Trizol (Life Technologies Inc.) according to
the manufacturer’s protocol. Next, cDNAs were synthesized from
1mg of the RNA with a Moloney murine leukemia virus-reverse
transcription kit (Life Technologies Inc.) using random hexamers.
The cDNAs were amplified by PCR for 30 cycles with AmpliTaq
Gold DNA polymerase (PerkinElmer Cetus, Norwalk, CN, USA) on
a thermal cycler with each primer (Table 1). The PCR conditions
were: pre-denaturation, 941C for 10min; denaturation, 941C for
60s; annealing, 651C for 60s; extension, 721C for 60s; and final
incubation, 721C for 10min. Reverse transcription–PCR was
performed twice.
Gelatin zymography
The gelatinolytic activity of matrix metalloproteinases-2 (MMP-2)
secreted in conditioned media was assayed by means of gelatin
Table 1 Primer sequence
Primer name Primer sequence (50 –30)
MMP-1-S TCGTGAGAATGTCTTCCCATT
MMP-1-AS TCTTGGATTGATTTGAGATAAGTGAAATC
MMP-2-S CGGCCGCAGTGACGGA
MMP-2-AS CATCCTGGGACAGACGGAAG
ZO-1-S CGGTCCTCTGAGCCTGTAAG
ZO-1-AS GGATCTACATGCGACGACAA
ZO-2-S GCCAAAACCCAGAACAAAGA
ZO-2-AS ACTGCTCTCTCCCACCTCCT
Snail-1-S GGGAAT TCTATGCCGCGCTCTTTCCTCGTC
Snail-1-AS GGGGATCCTCAGCGGGGACATCCTGAGCAG
Snail-2-S CTTTTTCTTGCCCTCACTGC
Snail-2-AS ACAGCAGCCAGATTCCTCAT
ZEB-1-S TGCACTGAGTGTGGAAAAGC
ZEB-1-AS TGGTGATGCTGAAAGAGACG
ZEB-2-S CGCTTGACATCACTGAAGGA
ZEB-2-AS CTTGCCACACTCTGTGCATT
TWIST-S GGAGTCCGCAGTCTTACGAG
TWIST-AS TCTGGAGGACCTGGTAGAGG
Vimentin-S AAGGGGACCAACGAGTCTCT
Vimentin-AS TGACATTCAGCAGGTCTTGG
E-cadherin-S TGATGCCCCCAATACCCCAG
E-cadherin-AS CTGTGGAGGTGGTGAGAGAG
Cytokeratin 19-S CCCGCGACTACAGCCACTA
Cytokeratin 19-AS GCTCATGCGCAGAGCCTGTT
GAPDH-S ACCTGACCTGCCGTCTAGAA
GAPDH-AS TCCACCACCCTGTTGCTGTA
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ssubstrate gel electrophoresis. Conditioned media were harvested
and the protein concentration was measured, followed by concen-
trating by precipitation with two volumes of absolute ethanol.
Protein (20mg) was re-suspended with two-sample buffer without
reducing agent (0.5 M Tris–HCl (pH 6.8), 10% SDS, 0.1% bromo-
phenol blue, 10% glycerol) and then subjected to 7.5% SDS–PAGE
gel containing 0.1% (w/v) gelatin without prior boiling. After
electrophoresis at 41C, the gel was washed with 2.5% Triton X-100
(v/v) for 30min, and subsequently incubated in substrate buffer
(50mM Tris–HCl (pH 7.5), 1mM ZnCl2,5 m M CaCl2)a t3 7 1C for
48–72h. The gel was then stained with 0.5% (w/v) Coomassie blue.
Proteolytic activities were detected by clear bands indicating the
lysis of the substrate. Gelatin zymography was carried out for
two times.
Flow cytometry
Apoptosis was detected using flow cytometry by staining cells
with Annexin V–FITC and propidium iodide (BD Pharmingen,
San Diego, CA, USA) labeling. OCUM-12 and OCUM-12/Hypo cells
were seeded at a density of 1.0 10
5 cells per ml in 100-mm plates.
Using an apoptosis kit, we stained cells with Annexin V–FITC and
propidium iodide according to the manufacturers’ instructions,
and immediately analysed using FACScan flow cytometry (Becton
Dickinson, Mountain View, CA, USA).
Statistical analysis
Data were analysed using Student’s t-test. P-values less than 0.05
were considered statistically significant.
RESULTS
Characterization of OCUM-12 and OCUM-12/Hypo cells
A hypoxia-resistant cell line, OCUM-12/Hypo, was successfully
established from OCUM-12, a parent scirrhous gastric cancer cell
line. The two cell lines show some morphologic and functional
differences. We observed that OCUM-12 cells were round, whereas
OCUM-12/Hypo cells were spindle shaped and showed epithelial-
to-mesenchymal transition (EMT) with reduced intercellular
adhesion (Figure 2A). The migratory ability of OCUM-12/Hypo
cells (Supplementary Movie 1) was greater in comparison to that of
OCUM-12 cells (Supplementary Movie 2). Both cell lines had
irregular nuclei of variable size. The doubling times estimated
from the growth curves of OCUM-12 and OCUM-12/Hypo were
13.4 and 24.9h, respectively. The doubling time estimated from the
growth curves of OCUM-12/Hypo was 20.0h, when they returned
to 20% O2. The levels of tumour-associated antigens CEA, CA19-9,
and SPan-1 were detected at 98.0ngml
 1, 5.8, and 6.0Uml
 1 in
OCUM-12 cells and 68.7ngml
 1, 22.3, and 7.5Uml
 1 in OCUM-
12/Hypo cells. The AFP levels were within the normal range
(o0.4ngml
 1) in both cell lines.
Chromosome analysis
The chromosome number varied between 71 and 78 (with a mode
of 75) for OCUM-12, and ranged between 61 and 69 (with a
mode of 67) for OCUM-12/Hypo. Of 50, 10 metaphase spreads
were karyotyped. Figure 2B shows the major karyotypic features
of OCUM-12 and OCUM-12/Hypo. The arrowheads indicate
rearranged chromosomes. The chromosome markers common to
the two cell lines were add(2)(q33), del(6)(q13), and add(19)(p13).
Other structural abnormalities of OCUM-12 were add(1)(p36),
del(1)(p32), add(4)(p11), del(3)(q26), der(5)add(5)(p15), add(5)
(q31), add(9)(p11), der(11)t(11;17)(p11;q11), der(11)t(11;17), add(13)
(q32), add(15)(q24), and add(16)(q11). Other structural abnor-
malities specific to OCUM-12/Hypo were add(2)(p23), del (5)
(q31q33), add(7)(p22), del(9)(p13), add(11)(p11.2), add(13)(q34),
and add(15)(p11.2).
Genetic alterations
The primary tumour, OCUM-12, and OCUM-12/Hypo cells all
showed an LOH at the p53 locus and DCC/DPC4 locus, whereas no
band shift was detected (Figure 2C). The same size alleles at
D18S35, D3S1611, and D5S346 (which detect DNA polymorphisms)
were found in normal epithelium, the primary gastric tumour,
OCUM-12, and OCUM-12/Hypo cells, thus showing that the
OCUM-12 and OCUM-12/Hypo cell lines are derived from the
same patient. In both cell lines, p53 sequencing analysis provided
evidence of C4T transition (arrow) at codon 273 in exon 8, which
leads to an amino-acid change from Arg4Cys (Figure 2D).
Scirrhous gastric carcinoma model in vivo
At 7 weeks after the orthotopic inoculation of OCUM-12 or
OCUM-12/Hypo cells in mice, gastric tumours were found in the
middle wall of the stomach (Figure 3A). Tumours composed of
OCUM-12/Hypo cells were associated with lymph node diseases
and peritoneal disseminations (Figure 3A), whereas those derived
from OCUM-12 cells showed few metastatic lesions. Orthotopic
tumours derived from both OCUM-12 and OCUM-12/Hypo cells
showed extensive fibrosis and the presence of poorly differentiated
adenocarcinoma cells (Figure 3B), which resembled human
scirrhous gastric carcinoma. Necrotic lesions were frequent in
OCUM-12 tumours but were rarely found in OCUM-12/Hypo
tumours (Figure 3B). The presence of hypoxia-associated
endogenous proteins, such as HIF-1a and CA9, and pimonidazole,
an exogenous marker, indicated that both tumour types had
hypoxic loci (Figure 3C). The staining of pimonidazole, HIF-1a,
and CA9 was heterogeneously positive in both the OCUM-12 and
the OCUM-12/Hypo tumours (Figure 3C). The necrotic regions in
the OCUM-12 tumours corresponded with HIF-1a or CA9-positive
regions.
Migratory and invasive ability
Figure 4A shows representative phase-contrast images of the
in vitro wound-healing assay. The number of migrating OCUM-12/
Hypo cells was about three times greater (Po0.01) than that of
OCUM-12 cells. Figure 4B shows representative phase-contrast
images of the in vitro invasion assay. The invasiveness of
OCUM-12/Hypo cells was 18 times greater (Po0.01) than that
of OCUM-12.
Expression of adhesion molecules and matrix
metalloproteinases
The mRNA expression levels of cell–cell adhesion molecules,
zonula occludens (ZO)-1, ZO-2, and E-cadherin, were lower in
OCUM-12/Hypo cells in comparison to the OCUM-12 cells.
However, the mRNA expression levels of vimentin, Snail-1,
Slug/Snail-2, Twist, ZEB-1, ZEB-2, MMP-1, and MMP-2 were
higher in OCUM-12/Hypo cells in comparison to the OCUM-12
cells (Figure 5A). The mRNA expression level of cytokeratin 19 was
not different between the two cell lines. Gelatinolytic activities
corresponding to pro-MMP-2 (68kDa) and the active form of
MMP-2 (62kDa) were detected in OCUM-12/Hypo cells but not
in OCUM-12 cells (Figure 5B).
Apoptosis
The apoptosis rate of OCUM-12 cells at 20% O2 was 2.1%. The
apoptosis rate of OCUM-12 cells at 1% O2 hypoxia was increased
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Figure 2 Morphology of OCUM-12 and OCUM-12/Hypo cells (A). OCUM-12 cells showed a round shape, whereas OCUM-12/Hypo cells were
spindle-shaped and formed loose cell aggregates. G-banded karyotypes of OCUM-12 and OCUM-12/Hypo (B). The representative karyotype of OCUM-
12 was XX,  Xo r Y, add (1)(p36), del[1] (p32), add (4)(p11), þadd (2)(q33), add(2)(q33), þ3[2], del(3)(q26), þ5, der(5)add(5)(p15), add(5)(q31),
þ6, del(6)(q13), del(6), þ7, þ8, þ9, add(9)(p11), add(9), þ10, þ11, der(11)t(11;17)(p11;q11), der(11)t(11;17) 2,  13, add(13)(q32), þ14,
add(15)(q24), add(16)(q11),  17,  18, þ19, add(19)(p13) 2, þ20,  21,  22, þmar1, þmar2. The representative karyotype of OCUM-12/Hypo.
XXY,  1,  2, der(2) add (2)(p23) add(2)(q33) 2,  4, þ5, del(5)(q31q33) 2, del(6)(q13) 2, þ7, add(7)(p22),  8, del(9)(p13),  10, þ11,
add(11)(p11.2) 2,  13,  13, add(13)(q34), þ14, add(15)(p11.2),  16,  17,  18, add(19)(p13), þ20,  21,  22, þ5–7 mar. Arrows, breakpoints
present. (C) Loss of heterozygosity analysis electropherograms using microsatellite markers. The primary gastric tumour, corresponding normal sample,
OCUM-12, and OCUM-12/Hypo cells are shown by comparing the height and position of peaks. The primary tumour, OCUM-12, and OCUM-12/Hypo
cells had LOH at the p53 locus and DCC/DPC4 locus, whereas no band shift was detected. The same size alleles at D18S35, D3S1611, and D5S346 probes
were found in normal epithelium, primary tumour, OCUM-12, and OCUM-12/Hypo cells, which shows that the OCUM-12 and OCUM-12/Hypo cell lines
are derived from the same patient. p53 sequencing analysis showed C4T transition (arrow) at codon 273 in exon 8 (D).
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(Figure 6).
DISCUSSION
In this study, we established a new hypoxia-resistant cell line,
OCUM-12/Hypo, that could grow in a 1% oxygen environment
from OCUM-12, a scirrhous gastric cancer cell line. Although
hypoxia is cytotoxic to OCUM-12 cells, some cancer cells acquire
characteristics that allow them to survive and grow in hypoxia (1%
oxygen). To the best of our knowledge, no other hypoxia-resistant
cell line has been reported. This is the first study to report the
establishment and characterization of a stable cancer cell line that
grows at low oxygen level. Because diffuse-type gastric cancer
shows less angiogenesis than intestinal-type carcinoma (Takahashi
et al, 1996), this cell type might more useful for studying the
conditions of chronic hypoxia in vivo than intestinal-type cells. In
this study, HIF-1a and CA9 staining of biopsy specimens revealed
that hypoxic loci existed in the primary diffuse-type gastric
tumour from which the OCUM-12 cell line was derived. The
hypoxia-resistant cells might be present in the parent OCUM-12
cells, and the OCUM-12/Hypo cells may have been selected in vitro
by continuous exposure to hypoxia. The doubling time estimated
from the growth curves of OCUM-12/Hypo cells was not different
in 20% oxygen and in 1% oxygen. The characteristic phenotypes of
OCUM-12/Hypo cells did not change when they were re-incubated
in 20% oxygen (data not shown), which indicates that the acquired
hypoxia resistance of OCUM-12/Hypo cells is irreversible and
OCUM-12/Hypo might be established as a clone. Moreover, we
attempted and subsequently failed to establish a hypoxia-resistant
cell line from other gastric cancer cell lines, including NU-GC-4
(Nomura et al, 2001), MKN7 (Motoyama et al, 1986), and MKN45
(Motoyama et al, 1986). The OCUM-12/Hypo cells were exposed to
20% O2 when passaged. However, the serial passages were carried
out quickly in a few minutes, and OCUM-12/Hypo cells were
returned to 1% O2 immediately. Moen et al (2009) indicated that
hyperoxia treatment for 90min might cause the mesenchymal-to-
epithelial transition ‘switches’ in vivo. In contrast, no morphologic
change was found during the serial passages, because our serial
passages were carried out for only a few minutes.
Microsatellite markers are valuable genetic markers for in-
dividual identification because they could detect DNA polymorph-
isms. The same size alleles at D18S35, D3S1611, and D5S346 probes
were found in normal epithelium, primary gastric tumour, OCUM-
12, and OCUM-12/Hypo cells, which shows that the OCUM-12 and
OCUM-12/Hypo cell lines are derived from the same patient.
We orthotopically injected OCUM-12 or OCUM-12/Hypo cells
into a murine stomach. Histologic findings of orthotopic tumours
by OCUM-12 and OCUM-12/Hypo showed a poorly differentiated
adenocarcinoma with extensive fibrosis, which resembled human
scirrhous gastric cancer. Immunohistochemical analysis based on
hypoxia-associated endogenous proteins such as HIF-1, CA9, or
pimonidazole, an exogenous marker that is preferentially trapped
in hypoxic cells, can yield tumour hypoxia information with direct
comparison to histologic findings (Takahashi et al, 1996). In this
study, necrotic lesions were detected in hypoxic areas of OCUM-12
tumours but were rarely found in OCUM-12/Hypo tumours,
OCUM-12 OCUM-12/Hypo
OCUM-12 OCUM-12/Hypo
Masson
trichrome
CA9 CA9
OCUM-12
Pimonidazole Pimonidazole
HIF1-α HIF1-α
OCUM-12/Hypo
H&E
(×100)
(×200)
H&E
Figure 3 Orthotopic implantation model with OCUM-12 cells and OCUM-12/Hypo cells. (A) An orthotopic tumour in the stomach (arrows) was found
7 weeks after inoculation in both cell lines. Orthotopic implantation model with OCUM-12/Hypo cells yielded lymph node diseases (arrowheads) and
peritoneal metastatic nodules (asterisks) 7 weeks after inoculation, whereas implantation with OCUM-12 cells developed few metastases. (B) Histologic
findings of inoculated OCUM-12 and OCUM-12/Hypo tumours. Orthotopic tumours with OCUM-12 and OCUM-12/Hypo showed extensive fibrosis with
the occasional presence of poorly differentiated adenocarcinoma cells. Masson’s trichrome staining showed blue multiple fibrosis in the orthotopic tumours.
Pimonidazole, HIF-1a, and CA9 staining were heterogeneously positive in OCUM-12 and OCUM-12/Hypo tumours (C).
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swhereas pimonidazole, CA9, and HIF-1a staining revealed both
areas to be hypoxic. Pimonidazole is positive at the hypoxic site
of tumour cells under conditions of partial oxygen tension
o10mmHg (Takahashi et al, 1996; Mayer et al, 2008). Orthotopic
tumours derived from either OCUM-12 or OCUM-12/Hypo cells
have heterogeneously hypoxic regions under and over 10mmHg O2.
These findings indicate that OCUM-12/Hypo cells have acquired
resistance to hypoxia and can survive in conditions with an oxygen
tension o10mmHg. Further studies are therefore necessary to
clarify the mechanisms responsible for survival in an environment
with a partial oxygen tension o10mmHg.
It has been reported that tumour hypoxia is associated with
more aggressive tumour phenotypes, which may lead to a poorer
prognosis for patients (Imai et al, 2003; Driessen et al, 2006; Mayer
et al, 2008). Our hypoxia models using OCUM-12/Hypo cells
showed frequent lymph node metastasis. Previous studies have
reported that the phenotypes of metastatic cancer cells are
associated with migration ability and EMT, which is characterized
by the loss of epithelial cell markers of cell–cell adhesion
molecules (Imai et al, 2003; Jung et al, 2006; Revenu and Gilmour,
2009). OCUM-12/Hypo cells are spindle shaped and show EMT,
whereas most OCUM-12 cells are round. The Supplementary
Movies show that OCUM-12/Hypo cells display increased pseudo-
pod formation, which is a prominent feature of actively motile
cells. The expression levels of the cell–cell adhesion molecules
ZO-1, ZO-2, and E-cadherin decreased in OCUM-12/Hypo cells.
These findings suggest that hypoxia-induced EMT of OCUM-12/
Hypo cells might be mediated through the regulation of cell–cell
adhesion molecules. An important aspect of EMT is the loss of
epithelial markers such as cytokeratin and E-cadherin, and the
upregulation of mesenchymal markers such as vimentin. In this
study, the mRNA expression level of E-cadherin was decreased and
that of vimentin was increased in hypoxia-resistant cells, whereas
that of cytokeratin 19 was not different. Kim et al (2009b) reported
that E-cadherin loss and the expression of vimentin was found to
be significantly associated with an unfavourable prognosis of
patients with gastric cancer, but no significant difference in patient
outcome was found regarding cytokeratin expression status.
Among epithelial and mesenchymal proteins, E-cadherin and
Vimentin expression might be linked to a more aggressive status
in gastric carcinoma, but cytokeratin expression might not be
correlated with malignant phenotype. The mRNA expression levels
of Snail-1, Slug/Snail-2, Twist, ZEB-1, ZEB-2 were higher in
OCUM-12/Hypo cells in comparison with the OCUM-12 cells.
Several transcription factors have been associated with the
repression of E-cadherin, including the Snail-1, Slug/Snail-2,
Twist, ZEB-1, and ZEB-2 (Imai et al, 2003; Moen et al, 2009).
These findings may show that hypoxia induces downregulation of
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Figure 4 The motility of OCUM-12 cells and OCUM-12/Hypo cells
in vitro.( A) Migration activity. Representative phase-contrast images of the
wound-healing assay show the migrating cells in the wound margin. The
number of migrating OCUM-12/Hypo cells was significantly (Po0.01)
greater than that of OCUM-12 cells. Dotted line, wound margin. (B)
Invasion activity. Representative phase-contrast images of the invasion assay
show a higher number of invading OCUM-12/Hypo cells in comparison to
OCUM-12 cells.
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Figure 5 mRNA expression and Gelatinolytic activity. (A) mRNA
expression. The mRNA expression levels of vimentin, Snail-1, Slug/Snail-2,
Twist, ZEB-1, ZEB-2, MMP-1, and MMP-2 were higher in OCUM-12/Hypo
cells in comparison to the OCUM-12 cells. The expression levels of
E-cadherin, ZO1, and ZO2 in OCUM-12/Hypo cells were lower than those
in OCUM-12 cells, whereas that of cytokeratin 19 was not different. (B)
Gelatinolytic activity. pro-MMP-2 (68kDa) and active MMP-2 (62kDa)
were detected in OCUM-12/Hypo cells, but not in OCUM-12 cells.
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the transcriptional repressor Snail, Twist, and ZEB families. Our
observations indicate that OCUM-12/Hypo cells have a greater
degree of invasive ability than OCUM-12 cells. The expression level
of type IV collagenase (MMP-2 and MMP-9) correlates to
carcinomatous malignancy (Sato et al, 2005). ProMMP-2 and
active MMP-2 were detected in OCUM-12/Hypo cells, but not in
OCUM-12 cells. Reverse transcription–PCR revealed that MMP-2
mRNA was expressed in OCUM-12/Hypo cells, but not in OCUM-
12 cells. A wound-healing assay also showed that the migration
capacity of OCUM-12/Hypo cells was much greater than that of
OCUM-12 cells. These findings suggest that a highly invasive
ability, MMP production, and a migratory ability (which are all
enhanced by hypoxic conditions) may underlie the increased
metastatic potential of hypoxic cancer cells.
Most gastric cancer cells produce various tumour-associated
antigens (Yashiro et al, 1995), which function as adhesion
molecules. Both cell lines produced the tumour-associated
antigens CEA and CA19-9 at high concentrations, although the
level of CEA was higher in OCUM-12 cells than in OCUM-12/Hypo
cells. Because CEA is reported to be a cell-to-cell adhesion
molecule (Benchimol et al, 1989), reduced CEA expression may
facilitate EMT in cells and may increase the invasive ability. The
CA19-9 production level was higher in OCUM-12/Hypo cells than
in OCUM-12 cells. Some studies have reported that the over-
expression of CA19-9 is responsible for adhesion to human
umbilical vein endothelial cells in liver metastatic lesions (Takada
et al, 1993). This ability to adhere to endothelial cells might enable
cancer cells to survive in hypoxic environments. The above-
mentioned findings suggest that differential expression of CEA and
CA19-9 in hypoxic cells might be associated with the development
of malignant potential in conditions of hypoxia.
Chromosome analysis showed many chromosome aberrations.
One chromosome marker add(19)(p13) was common to both
cell lines. Some hypoxia-associated genes, including follistatin
like 3 (FSTL3), CA9, mitogen-activated protein kinase organizer
1( MORG1), and angiopoietin-like 4 (ANGPTL4), are located near
9p13 (Hayette et al, 1998; Biron-Shental et al, 2008). The
upregulation of FSTL3 mRNA has previously been observed as a
response to hypoxia in human trophoblasts, thus suggesting a role
for HIF1-a (Biron-Shental et al, 2008). Carbonic anhydrases are a
large family of zinc metalloenzymes that catalyse the reversible
hydration of carbon dioxide. They participate in a variety of
biologic processes, including respiration, acid-base balance, and
bone resorption. CA9 is expressed in epithelial cells with high
proliferative capacities, thus supporting its role in cell prolifera-
tion. This CA has been implicated in the regulation of the
microenvironmental pH by conversion of carbon dioxide into
bicarbonate and hydrogen. Carbon dioxide and lactate, produced
during anaerobic glycolysis in tumours, are important sources of
acidity, which promotes tumour growth and metastasis. Based on
these features, CA9 is not only a tumour marker but also appears
to be directly involved in the oncogenesis of different types of
tumours. MORG1 enhances ERK activation at low concentrations,
whereas high concentrations lead to the inhibition of ERK acti-
vation. ANGPTL4 is a member of the angiopoietin/angiopoietin-
like gene family and encodes a glycosylated, secreted protein with a
fibrinogen C-terminal domain. This gene is induced under hypoxic
conditions in endothelial cells and is the target of peroxisome
proliferation activators. The encoded protein is a serum hormone
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Figure 6 Apoptosis induction by hypoxia. (A) The typical examples of flow cytometric analysis. (B) In OCUM-12 cells, hypoxia induced apoptosis at a
rate of 24.7%, whereas apoptosis rate at 20% O2 was 2.1%. In contrast, the apoptosis rate of OCUM-12/Hypo was 5.6% at hypoxia. The result represents
the mean of three independent experiments and the bars show the s.d.
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sdirectly involved in regulating glucose homeostasis, lipid metabo-
lism, and insulin sensitivity, and it also functions as an apoptosis
survival factor for vascular endothelial cells. The encoded protein
may have a role in several cancers and has been shown to repress
the metastatic process by inhibiting vascular activity as well as
tumour cell motility and invasiveness.
Structural abnormalities of OCUM-12/Hypo include add(2)
(p23), where human xanthine dehydrogenase is located (Ichida
et al, 1993). Xanthine dehydrogenase belongs to the group of
molybdenum-containing hydroxylases involved in the oxidative
metabolism of purines. The enzyme complex exists in separate
but inter-convertible forms, namely xanthine dehydrogenase
and xanthine oxidase, which generate reactive oxygen species,
a causative factor in ischemia/reperfusion injury and other
pathologic states and diseases. Xanthine oxidoreductase expres-
sion in gastric cancer may be a new marker for more aggressive
gastric cancer biology (Linder et al, 2006).
In the most hypoxic regions of tumours, p53 is stabilized and
induces apoptosis. Recent studies have suggested that mutations in
p53, a tumour suppressor gene, may be important in regulating the
adaptive response of tumour cells to hypoxia by enhancing their
survival and the release of pro-angiogenic factors (Kieser et al,
1994). It has even been suggested that the more malignant clones
harbouring genetic defects such as mutations in p53 might be
selected by hypoxia for the survival (Royds et al, 1998). In both
OCUM-12 and OCUM-12/Hypo cells, p53 mutation in exon 8 and
LOH at the p53 locus were detected. A typical sequence for the loss
of tumour suppressor genes in a neoplasm is an inactivating
mutation at one allele, followed by LOH affecting the other allele.
These findings suggest that both cell lines show a p53 function loss
because of p53 mutation in one allele and LOH at the other allele.
Our data indicate that loss of p53 function might have important
role in tumour cell growth under hypoxic conditions.
In conclusion, we have established two new scirrhous gastric
cancer cell lines, designated OCUM-12 and OCUM-12/Hypo.
OCUM-12/Hypo cells can survive and grow in an environment of
chronic hypoxia and show more frequent EMT, increased
migratory and invasive activities, and higher metastatic potential
than OCUM-12 cells. Our findings suggest that chronic hypoxia
enhances the malignant phenotype of cancer cells. These two cell
lines should be beneficial for the elucidation of the disease
progression of scirrhous gastric cancer in chronic hypoxic
conditions in vitro and in vivo.
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